云南高校图书馆联盟文献共享服务平台- SCLC

SCLC: 作品数：345被引量：960H指数：10; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：赵路军徐利明程颖王平袁智勇更多>>; 相关机构：天津医科大学吉林省肿瘤医院中国医学科学院肿瘤医院首都医科大学附属北京胸科医院更多>>; 相关期刊：更多>>; 相关基金：国家自然科学基金国家重点基础研究发展计划浙江省医药卫生科学研究基金徐州市科技计划项目更多>>

Evaluating the efficacy and safety of Anlotinib in conjunction with stereotactic radiosurgery for small cell lung cancer patients with brain metastases: 《Oncology Research》2025年第4期885-894,共10页LIZHI WANG HUILIN SUN GUIZHI YU ZEJING QU YING JI YANPING CUI; supported by the Science and Technology Program of Chengde(Project Number:202301A016).; Background:Small cell lung cancer(SCLC)is characterized by its aggressive nature and high propensity for brain metastases.This study investigates the clinical efficacy and safety profile of Anlotinib in combination wi...; 关键词：Small cell lung cancer(SCLC) Brain metastasis Anlotinib Stereotactic radiotherapy Intracranial progression-free survival

基于PET-CT及血清学标志物的早期SCLC及NSCLC鉴别诊断模型构建: 《安徽医学》2025年第2期202-205,共4页宋晏陈正福冯昭范志刚付伟; 陕西省重点研发计划项目(编号:2021SF-044)。; 目的探讨早期小细胞肺癌(SCLC)和非小细胞肺癌(NSCLC)鉴别诊断独立预测因子并进一步构建基于PET-CT及血清学标志物的鉴别诊断模型。方法回顾性分析2021年3月至2024年1月于通用医疗陕西汉中三二〇一医院诊治的225例肺癌患者的临床资料...; 关键词：小细胞肺癌非小细胞肺癌体层摄影术氟脱氧葡萄糖F18 鉴别诊断

小细胞肺癌分子分型标志物在宫颈小细胞神经内分泌癌中的应用:NEUROD1为一种不良预后因素: 《诊断病理学杂志》2025年第2期187-187,共1页吴剑萍(摘译) 黄海建(审校); 宫颈小细胞神经内分泌癌(CSCNEC)是一种罕见的侵袭性宫颈癌。CSCNEC与小细胞肺癌(SCLC)具有相似的临床和组织学特征,因此CSCNEC采取了类似于SCLC的化疗方案。作者首次应用了神经内分泌(NE)和SCLC分子分型免疫组织化学标记物ASCL1、NEUR...; 关键词：小细胞肺癌不良预后因素免疫标记物 SCLC ROD 组织学特征分子分型神经内分泌

关于关键词的标引: 《实用肿瘤学杂志》2025年第1期6-6,共1页本刊编辑部; 论文中需标注3~5个关键词,请务必使用美国国立医学图书馆编辑的最新版《Index Medicus》医学主题词表(MeSH)内所列出的词,也可以通过上网查检索词。如MeSH上尚无相应的主题词,处理办法:(1)选用直接相关的几个主题词进行组配;(2)选用约...; 关键词：小细胞肺癌自由词医学主题词表 SCLC 主题词检索词

Genetic signatures of ERCC1 and ERCC2 expression,along with SNPs variants,unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy: 《Oncology Research》2025年第1期45-55,共11页ENRICO CALIMAN SARA FANCELLI FEDERICO SCOLARI ADRIANO PASQUI CLARA MANNESCHI DANIELE LAVACCHI FRANCESCA MAZZONI FRANCESCA GENSINI VALERIA PASINI CAMILLA EVA COMIN LUCA VOLTOLINI SERENA PILLOZZI LORENZO ANTONUZZO; Background:Platinum chemotherapy(CT)remains the backbone of systemic therapy for patients with smallcell lung cancer(SCLC).The nucleotide excision repair(NER)pathway plays a central role in the repair of the DNA damag...; 关键词：Small cell lung cancer(SCLC) Nucleotide excision repair(NER)pathway ERCC genes Single nucleotide polymorphisms(SNPs) Platinumchemotherapy(CT)

Ubiquitin-specific protease 1 facilitates tumor immune escape from natural killer cells and predicts the prognosis in small cell lung cancer: 《Oncology Research》2025年第1期213-224,共12页SHIQIN JIANG YICHUN TANG FENG MA YUCHUN NIU LEI SUN; supported by grants from the Dongguan Science and Technology of Social Development Program(No.20231800940192);the Talent Development Foundation of the First Dongguan Affiliated Hospital of Guangdong Medical University(No.PU2023002).; Objective:Small cell lung cancer(SCLC)is commonly recognized as the most fatal lung cancer type.Despite substantial advances in immune checkpoint blockade therapies for treating solid cancers,their benefits are limite...; 关键词：Ubiquitin-specific protease 1(USP1) Natural killer(NK)cell Small cell lung cancer(SCLC) PROGNOSIS Immune escape

Transformation of lung adenocarcinoma into small cell lung cancer after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: 《Oncology and Translational Medicine》2024年第6期286-291,共6页Linwu Kuang Yangkai Li; Epidermal growth factor receptor tyrosine kinase inhibitors effectively improve the prognosis of patients with epidermal growth factor receptor–mutant lung adenocarcinoma.However,acquired resistance inevitably develo...; 关键词：Small cell lung cancer transformation Lung adenocarcinoma EGFR-TKIS SCLC Drug resistance

Comparison of irinotecan/carboplatin versus etoposide/carboplatin for extended disease small cell lung cancer(ED-SCLC):A systematic review and meta-analysis of randomized controlled trials: 《Malignancy Spectrum》2024年第4期300-311,共12页Zeeshan Afzal Sara Hira Xia Song Na Wang; Background:Platinum-based chemotherapy in addition to the nonplatinum agent etoposide is the standard of care for extensive-stage small cell lung cancer(ES-SCLC).However,the front-line chemotherapy regimen is not know...; 关键词：CARBOPLATIN ED-SCLC ETOPOSIDE IRINOTECAN small cell lung cancer

Real-world Efficacy Analysis of Combined Chinese and Western Medicine in the Treatment of Extensive-stage Small Cell Lung Cancer: 《Proceedings of Anticancer Research》2024年第6期198-208,共11页Kai Tan Changhui Zhang Puhua Zeng; National Natural Science Foundation of China(Project No.:82074425);Young Qihuang Scholars Talent Project of National Administration of Traditional Chinese Medicine;Top Technology Leading Talents Project of Hunan Province;Key R&D projects in Hunan Province(Project No.:2021SK2006);Natural Science Foundation of Hunan Province(Project No.:2021JJ30417);Hunan Provincial Engineering Research Center of Anti-tumor Chinese Medicine Creation Technology Project;Hunan Provincial Health Commission Traditional Chinese Medicine Shennong Leading Talent Project。; Objective:To explore the efficacy of integrated traditional Chinese and Western medicine in the treatment of extensive-stage small cell lung cancer(ES-SCLC).Methods:Patients who were hospitalized and outpatients in th...; 关键词：Extensive-stage small cell lung cancer(ES-SCLC) Real-world study(RWS) IMMUNOTHERAPY CHEMOTHERAPY Traditional Chinese medicine(TCM)

小细胞肺癌的影像新进展: 《实用放射学杂志》2024年第12期2087-2090,共4页董书含(综述) 殷小平(审校); 小细胞肺癌(small cell lung cancer,SCLC)约占所有肺癌的13%~15%,是肺癌中预后最差的一种类型,在美国每年有30000~35000例新发病例[1]。SCLC对放化疗敏感,且相比于广泛期SCLC,局限期SCLC的放疗效果更好,但大多数患者在确诊时已伴有其...; 关键词：局限期放疗效果新进展综述小细胞肺癌影像学技术治疗及预后 SCLC 早期诊断

SCLC